mRNA medicines represent the genesis of a fourth pillar of pharma innovation. While exciting, there are several critical challenges we must solve to strengthen this pillar, including stability and deliverability.
- Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah
- NK Cell Therapies: How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
- Improving Governance And Compliance With Knowledge Management
- China’s Rising Role On The Global Stage In The Oncology Market
- GMP Plant Uniform Lockers And Procedures: Best Practices
- A Deeper Look At What's Driving Dependence On Biotech Contract Manufacturers
- Developing A Process Performance Qualification Master Plan For Gene Therapies
- What Time Is Best To Bring My CDMO On Board?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Chromatography Solutions For AAV Full And Empty Capsid Separation
Effective separation of full and empty AAV capsids requires implementation of purification strategies that differ from standard approaches used for traditional modalities. Explore two cases describing such approaches.
-
Volume Verification Using Any Microtiter Plate Or Small Volume Container
Here, we discuss methods for measuring target volumes (10 nL - 200 μL) dispensed into any microtiter plate or small-volume container using the Artel MVS®.
-
Single Cell Isolation With Minimal Input
Learn about the single cell isolation efficiency of this single cell dispenser with a low sample input of 100 cells with both adherent and non-adherent cell lines.
-
Comprehensive Peptide Mapping Of Protein Therapeutics
Explore how the peptide mapping workflows templates provided by a software designed for the characterization of biotherapeutic digests alongside data visualization and interrogation.
-
Untouched Tumor Cell Isolation Improves NGS Analysis, Enrichment Of Cancer Stem Cells
Here, bulk tumor and isolated tumor cells were subjected to whole exome sequencing (WES) to assess the impact of non-tumor cell depletion on the sensitivity of downstream NGS analyses.
-
CGT Trials — The Synergy Of CRO And Specialty Logistics Collaboration
Learn how the right CRO partner is crucial to support the uniquely complex logistical needs of CGTs while prioritizing the working conditions of investigators and the comfort of trial participants.
-
Target T Cell Isolation And Magnetic Bead Removal At High Efficiency
Explore a cell processing platform using magnetic beads to support the cell therapy industry through struggles with challenges such as product quality and slow, inefficient manufacturing processes.
-
Precision Volume Accounting In Fed-Batch Cultures
Are you searching for a better way to calculate growth rate? Explore a new approach that performs the rate calculations using a simple method to correct for volume changes.
-
Optimizing Accuracy Performance On A Beckman Coulter Biomek
Explore an approach for optimizing pipetting accuracy on a Beckman Coulter Biomek liquid handler using MVS® measurement information.
-
A Simple Solution Slashes Cell Line Development At A Biotech Company
A biotech company's cell line development team decided to optimize their processes and look for new equipment that could isolate single cells and speed up development.
NEWSLETTER ARCHIVE
- 04.25.24 -- Insights From Across The Globe: Trends In Clinical Trials
- 04.25.24 -- Reducing The Disease Burden Of AML With Vor Bio's Dr. Robert Ang
- 04.24.24 -- Outsourcing Best Practices To Increase Efficiency And Compliance
- 04.24.24 -- Cell Counting Is Growing More Important Amid Advanced Therapy's Rise
- 04.23.24 -- Inside Tenaya Therapeutics' AAV9-Based Gene Therapy
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections